BONUS - The FDA Grants Emergency Use Authorization for COVID-19 Vaccine for Kids Ages 5-11—What’s Next? - a podcast by Johns Hopkins Bloomberg School of Public Health

After months of scrutinizing data from clinical trials, the FDA granted Emergency Use Authorization of Pfizer’s COVID-19 vaccine for children 5-11. Many parents and guardians are eager for their child to be first in line but what do those who might feel hesitant need to know? Dr. Gigi Gronvall, parent and immunologist at the Center for Health Security, returns to the podcast to talk with Stephanie Desmon about the importance of vaccinating kids, why it’s not worth it to wait for the “adult” dose for kids who are 11, and why authorization took longer for children than for adults. 

Further episodes of Public Health On Call

Further podcasts by Johns Hopkins Bloomberg School of Public Health

Website of Johns Hopkins Bloomberg School of Public Health